欧美日本一道本一区二区_亚洲免费影视_91手机在线看片_精品欧美成人高清在线观看_少妇作爱bbbb免费看_51久久夜色精品国产水果派解说

美國Nephros   
nephros公司，總部在新澤西州，是一家醫(yī)療器械公司，開發(fā)和銷售治療應(yīng)用，感染控制，水凈化過濾產(chǎn)品。Nephros血液透析濾過（HDF）系統(tǒng)的設(shè)計，而解決的關(guān)鍵財務(wù)和臨床保健提供者的需求，改善終末期腎臟疾病（ESRD）患者的生活質(zhì)量。終末期腎功能不可逆轉(zhuǎn)的喪失為特征的一種疾病狀態(tài)。Nephros的HDF系統(tǒng)更有效地消除各種有害物質(zhì)，并具有更大的容量，比現(xiàn)有的終末期的治療方法，特別是就統(tǒng)稱為物質(zhì)，“中間分子。” 這些分子已發(fā)現(xiàn)有助于透析相關(guān)性淀粉樣變，腕隧道癥候群，退化性骨骼疾病，并最終在終末期腎病患者的死亡率等條件。Nephros雙級超濾（DSU）Nephros水過濾產(chǎn)品線，其中包括密歇根州立大學(xué)和語常會辦事處超濾的基礎(chǔ)上。專利的雙級冷殺菌超濾過濾掉細菌，由于其特殊的過濾水平，篩選出很多病毒，寄生蟲和毒素的能力。Nephros DSU的密歇根州立大學(xué)，和語常會辦事處是FDA在血液透析過程中使用的生物污染物從水和碳酸氫鹽濃縮過濾清除。nephros“DSU的超濾正在評估在美國幾個主要的醫(yī)療中心感染控制。nephros還開發(fā)飲用水凈化UF-40超濾在戰(zhàn)場上的士兵。

Nephros, Inc. was founded in 1997 by Columbia University health for the End Stage Renal Disease (ESRD) patient, while addressing
the critical needs of the care provider. The Company has developed the most effective ESRD therapy available worldwide, offering unique
and proprietary technologies that dramatically improve clinical efficacy.
Nephros technologies also remove a range of harmful substances not currently removed by existing dialysis methods; addressed specifically
are substances known collectively as middle molecules, due to their molecular weight, that contribute to such conditions as carpal tunnel
syndrome, dialysis related amyloidosis, and degenerative bone disease in the ESRD patient.
Founded in 1997 to address current voids in ESRD treatment:

Stale Methodologies
Cost and Reimbursement Issues
Quality of Care Issues
Nephros technology focus:
Unique and cost-effective proprietary technologies
Marked improvements in treatment efficacy per unit time
Platforms: easy to use and maintain
Technology that integrates well with existing mfg and clinical
infrastructures